Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRONULIFE IntProtect is a functional probiotic blend developed by GLAC Biotech Co., Ltd. for use in dietary supplements and functional foods. As part of the PRONULIFE blended probiotic series, it is designed to support intestinal health and maintain gut microbiota balance. The formulation utilizes proprietary PRONEX technology to ensure the stability and quality of the probiotic strains. It is intended for oral administration to provide digestive support and promote overall gastrointestinal wellness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PRONULIFE IntProtect.